BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Chi-Med Reports Preliminary Phase II Data On Fruquintinib Combination In First-Line Lung Cancer

  Hutchison China MediTech Limited today reported preliminary clinical activity, safety, and tolerability data of fruquintinib.

  October 16, 2017

   · 

  6 min read
• Business

  QIAGEN N.V. To Report Third Quarter And First Nine Months Of 2017 Results

  QIAGEN N.V. plans as previously announced to release its report on results for the third quarter and first nine months of 2017 on Monday, November 6 at approximately 22:00 Central European Time (CET) / 16:00 Eastern Time (EDT).

  October 16, 2017

   · 

  2 min read
• Drug Development

  Bristol-Myers Squibb Release: Opdivo Alone Or Combined With Yervoy In Exploratory Analysis From Phase I/II Study Checkmate -032

  Bristol-Myers Squibb Company today announced data evaluating Opdivo (nivolumab) and Opdivo plus Yervoy (ipilimumab) from the Phase 1/2 CheckMate -032 trial.

  October 16, 2017

   · 

  29 min read
• Business

  Sigilon Therapeutics Introduces Scientific Advisory Board For Guiding Development of Afibromer Living Therapeutics

  Sigilon Therapeutics today announced the formation of a scientific advisory board.

  October 16, 2017

   · 

  3 min read
• Orthocell Granted Celgro Patent Protection In Canada

  Regenerative medicine company Orthocell Limited is pleased to announce it has been granted a Canadian patent for its CelGro collagen medical device platform for soft tissue regeneration and repair applications.

  October 16, 2017

   · 

  3 min read
• Drug Development

  Mithra Announces Completion Of Recruitment In Donesta Phase II Study

  Mithra, a company specialized in Women’s Health, today announces the completion of recruitment in the E4 Relief Phase II study of Donesta.

  October 16, 2017

   · 

  5 min read
• Drug Development

  Karolinska Development’s Portfolio Company Aprea Announces First Patient Enrolled In Clinical Phase Ib/II Study With APR-246 For The Treatment Of Esophageal Cancer

  Karolinska Development today announces that the portfolio company Aprea Therapeutics AB has enrolled the first patient in a Phase 1b/2 study with the drug candidate APR-246 for the treatment of esophageal cancer.

  October 16, 2017

   · 

  2 min read
• Biotech Beach

  REVA Announces Commercial Expansion and the First Implant of the Fantom Bioresorbable Scaffold in Switzerland

  REVA Medical announced the commercial expansion of its bioresorbable scaffold (“BRS”), Fantom, with the first implant in Switzerland.

  October 16, 2017

   · 

  3 min read
• Business

  Batavia Biosciences Expands Its Viral Vector And GMP Facilities To Accommodate Increasing Market Demand

  Today, Batavia Biosciences announces the expansion of its viral vector process development facilities in the USA and its GMP clean room facilities in the Netherlands to accommodate the increasing market demand.

  October 16, 2017

   · 

  1 min read
• Almac Pod - Changing The Global Dynamics Of Temperature Controlled Shipping Solutions

  Almac Group has recognized the need for a change in dynamics of temperature controlled shipping with the launch of its new Almac Pod service solution in the United States.

  October 16, 2017

   · 

  2 min read